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he lipid products of phosphoinositide 3-kinase
(PI3K) are involved in many cellular responses such
as proliferation, migration, and survival. Disregulation
of PI3K-activated pathways is implicated in different
diseases including cancer and diabetes. Among the three
classes of PI3Ks, class I is the best characterized, whereas
class II has received increasing attention only recently and
the precise role of these isoforms is unclear. Similarly, the
role of phosphatidylinositol-3-phosphate (PtdIns-3-P) as
an intracellular second messenger is only just beginning
T
 
to be appreciated. Here, we show that lysophosphatidic
acid (LPA) stimulates the production of PtdIns-3-P through
activation of a class II PI3K (PI3K-C2
 
 
 
). Both PtdIns-3-P
and PI3K-C2
 
 
 
 are involved in LPA-mediated cell migration.
This study is the ﬁrst identiﬁcation of PtdIns-3-P and PI3K-
C2
 
 
 
 as downstream effectors in LPA signaling and
demonstration of an intracellular role for a class II PI3K.
Deﬁning this novel PI3K-C2
 
 
 
–PtdIns-3-P signaling path-
way may help clarify the process of cell migration and
may shed new light on PI3K-mediated intracellular events.
 
Introduction
 
Over the last few years, the intracellular role of phosphoinositide
3-kinases (PI3Ks), the family of enzymes responsible for
generation of 3-phosphorylated phosphoinositides, has been
extensively investigated and it is now established that PI3Ks
are crucial components of many signaling pathways playing a
pivotal role in many different physiological events (Rameh and
Cantley, 1999; Cantley, 2002). Furthermore, it is also well
documented that altered PI3K-dependent pathways are impli-
cated in different diseases including cancer and diabetes
(Katso et al., 2001). Although different PI3Ks have been
identified and grouped into three classes (Foster et al., 2003),
the majority of these studies focused on members of class I and
their main in vivo product phosphatidylinositol-3,4,5-trisphos-
phate (PtdIns-3,4,5-P
 
3
 
).
Recently, a growing interest has arisen in the members of
class II PI3K and several lines of evidence suggest a potential
role for these enzymes in agonist-mediated regulation of cellular
functions (Foster et al., 2003). Such evidence includes activation
of PI3K-C2
 
 
 
 by insulin (Brown et al., 1999) and monocyte
chemotactic peptide-1 (Turner et al., 1998) and through inter-
action with clathrin (Gaidarov et al., 2001). Similarly, insulin
(Brown and Shepherd, 2001) and platelet aggregation (Zhang
et al., 1998) have been reported to activate PI3K-C2
 
 
 
. In addi-
tion, PI3K-C2
 
 
 
 and PI3K-C2
 
 
 
 associate with polypeptide
growth factor receptors (Arcaro et al., 2000) and recent data
suggest that PI3K-C2
 
 
 
 is involved in EGF- and stem cell factor–
dependent signals (Arcaro et al., 2002). Despite this evidence, a
clear mechanism of activation and the precise intracellular roles
of these enzymes are still not defined (Foster et al., 2003). Fur-
thermore, there is currently no clear indication of their in vivo
lipid products (Foster et al., 2003), although the observation
that, in vitro, these enzymes display a strong substrate prefer-
ence for phosphatidylinositol suggests phosphatidylinositol-3-
phosphate (PtdIns-3-P) to be their main lipid product in vivo
(Brown and Shepherd, 2001).
The role of PtdIns-3-P as a dynamic intracellular second
messenger has been recently underscored by our work reporting
that this phosphoinositide is generated upon insulin stimulation
(Maffucci et al., 2003) and the demonstration that it plays a
crucial role in insulin signaling (Chaussade et al., 2003; Maf-
fucci et al., 2003). Evidence suggests that the insulin-dependent
pool of PtdIns-3-P might be generated through activation of a
class II PI3K enzyme (Maffucci et al., 2003).
Lysophosphatidic acid (LPA; 1-acyl-
 
sn-
 
glycerol-3-phos-
phate) is a serum-borne phospholipid that evokes a wide range
of biological effects, including cell proliferation, migration,
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and survival (Moolenaar, 1994; Graler and Goetzl, 2002; Mills
and Moolenaar, 2003; van Leeuwen et al., 2003). This large
spectrum of biological activities is explained by the fact that
LPA receptors can couple to three distinct G proteins, Gq, Gi,
and G
 
12/13
 
, leading to activation of several intracellular messen-
gers, including phospholipase C (PLC), the small GTPases
RhoA and Rac, the Ras–MAPK cascade, and PI3K (Radeff-
Huang et al., 2004). Two members of class I PI3K (p110
 
 
 
 and
p110
 
 
 
) have been reported to be involved in LPA signaling
(Yart et al., 2002). In particular, p110
 
 
 
 can be directly acti-
vated by G protein 
 
  
 
 subunits through association with the
adaptor protein p101 (Stephens et al., 1997) and it has been im-
plicated in the LPA-dependent Ras–MAPK activation (Takeda
et al., 1999) and motility (Jung et al., 2004). Furthermore, it has
been shown that at least in some cell lines the LPA-dependent
accumulation of PI3K products is mediated by p110
 
 
 
 in a
mechanism involving transactivation of the EGF receptor (Laf-
fargue et al., 1999).
Among the different effects elicited by LPA, migration
has recently received increasing attention (Gschwind et al.,
2003; Stahle et al., 2003; van Leeuwen et al., 2003; Yamada et
al., 2004). The importance of LPA in migration has been un-
derscored by the discovery that autotaxin, a cell motility-stimu-
lating ectophosphodiesterase involved in tumor invasion, can
act as a lysophospholipase D and generate LPA from lysophos-
phatidylcholine in the extracellular environment (Umezu-Goto
et al., 2002). Indeed, both LPA and autotaxin have been in-
volved in motility of neoplastic and nonneoplastic cells (Hama
et al., 2004). Cell migration is the result of different and well-
coordinated physical processes and orchestrates embryonic
morphogenesis, contributes to tissue repair and regeneration,
and drives disease progression in cancer, atherosclerosis, and
arthritis. Several lines of evidence suggest that 3-phospho-
inositides play a role in directed migration via both G protein–
and tyrosine kinase–mediated signaling processes. Here, we
identify a novel pathway in LPA signaling that involves genera-
tion of the lipid second messenger PtdIns-3-P through activation
of PI3K-C2
 
 
 
 and is crucial for LPA-dependent cell migration.
This study is the first demonstration of an intracellular role for
a class II PI3K and identification of two new important players
in cell migration.
 
Results
 
LPA generates the intracellular second 
messenger PtdIns-3-P
 
We have recently demonstrated for the first time that PtdIns-3-P
can act as a lipid second messenger and plays a crucial role in
insulin signaling (Maffucci et al., 2003). This observation, to-
gether with our previous work reporting that LPA can generate
PtdIns-3-P in COS7 cells (Razzini et al., 2000), prompted us to
further investigate the effects of LPA stimulation on the levels
of the PI3K products in different cell lines. HPLC analysis re-
vealed that LPA stimulated the production of PtdIns-3-P in
 
3
 
H-labeled COS7 (Fig. S1, A and B, available at http://
www.jcb.org/cgi/content/full/jcb.200408005/DC1), HeLa cells
(Fig. 1 A), and an ovarian cancer cell line (SKOV-3; Fig. 1 B).
It is important to underline that resting mammalian cells con-
tain high basal levels of PtdIns-3-P (Rameh and Cantley,
1999); therefore, the apparent small increase upon LPA stimu-
lation actually corresponds to a large amount of this phosphoi-
nositide being generated de novo.
When we analyzed PtdIns-3,4,5-P
 
3
 
, we observed that
the levels of this phosphoinositide were very low in resting
COS7 but rapidly increased upon LPA stimulation (Fig. S1
C), as reported previously (Laffargue et al., 1999). In con-
trast, HPLC analysis of 
 
3
 
H-labeled cells revealed that both
SKOV-3 (Fig. S2 A, available at http://www.jcb.org/cgi/
Figure 1. LPA generates specifically PtdIns-3-P in HeLa and SKOV-3. HeLa
(A) and SKOV-3 (B) were labeled with [
3H]-myo-inositol for 24 h and
stimulated with 25  M LPA for the indicated times. Phospholipids were
then extracted, deacylated, and analyzed by HPLC. Levels of PtdIns-3-P are
shown as a percentage of basal levels. Data are mean   SEM of three to
four (HeLa) and three to eight (SKOV-3) independent experiments. (C) Se-
rum-starved HeLa were labeled with [
32P]phosphoric acid for 3 h and stimu-
lated with 25  M LPA for the indicated times. Phospholipids were then ex-
tracted and analyzed by TLC. (D) Levels of PtdIns-3,4,5-P3 in 
3H-labeled
HeLa assessed at different times of EGF stimulation by HPLC analysis. Data
are mean   SEM of three independent experiments. (E) Western blotting
analysis of lysates from serum-starved HeLa stimulated with 25  M LPA for
the indicated times. Phosphorylation of Akt on residue Ser473 and Thr308
was assessed by using specific antibodies. Filters were stripped and reprobed
with an anti-Akt antibody. (F) Western blotting analysis of lysates from
serum-starved SKOV-3 stimulated with 25  M LPA for the indicated times.
Phosphorylation of Akt and total Akt levels were assessed by using specific
antibodies. (G) LPA-dependent activation of PLC was assessed by monitor-
ing the levels of total inositol phosphates generated. Data are from the
experiment performed in parallel with the experiment shown in F. (H) Western
blotting analysis of lysates from serum-starved SKOV-3 stimulated with
20 ng/ml EGF for the indicated times. Phosphorylation of Akt and total Akt
levels were assessed by using specific antibodies. 
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content/full/jcb.200408005/DC1) and HeLa (unpublished data)
possessed high basal levels of PtdIns-3,4,5-P
 
3
 
 that were unaf-
fected by LPA stimulation. As an alternative method to detect
and visualize PtdIns-3,4,5-P
 
3
 
, phospholipids were extracted
from 
 
32
 
P-labeled cells and analyzed by TLC. Stimulation with
LPA for different times did not increase the basal levels of Ptd-
Ins-3,4,5-P
 
3
 
 in HeLa (Fig. 1 C). However, a clear increase in
PtdIns-3,4,5-P
 
3
 
 was observed in HeLa upon EGF stimulation
in experiments performed in parallel (HPLC analysis of 
 
3
 
H-
labeled cells: Fig. 1 D; TLC analysis of 
 
32
 
P-labeled cells: see
Fig. 3 C). We checked the phosphorylation state of the well-
established PtdIns-3,4,5-P
 
3
 
 target protein kinase B/Akt. As a
consequence of the observed high basal levels of PtdIns-
3,4,5-P
 
3
 
, phosphorylation of Akt was already detectable in
unstimulated HeLa (Fig. 1 E) and SKOV-3 (Fig. 1, F and H).
LPA stimulation for different times did not induce a further
phosphorylation of Akt in either cell line (Fig. 1, E and F).
Efficiency of LPA in stimulating these cells was confirmed
by monitoring PLC activation in parallel experiments (Fig. 1
G, representative example of PLC activation in SKOV-3 in
the experiment performed in parallel to the experiment shown
in Fig. 1 F). The possibility that Akt was already maximally
activated in these cells and therefore could not be further
stimulated was ruled out by the observation that EGF induced
a clear increase in phosphorylation of Akt in SKOV-3 (Fig. 1
H) as previously reported (Anderson et al., 2001). Similar re-
sults were obtained in HeLa (unpublished data). Together,
these results indicate that LPA specifically stimulates PtdIns-
3-P synthesis without detectably affecting the levels of Ptd-
Ins-3,4,5-P
 
3
 
 at least in HeLa and SKOV-3.
 
The LPA-dependent pool of PtdIns-3-P is 
generated at the plasma membrane
 
To localize the LPA-dependent pool of PtdIns-3-P, cells were
transfected with a cDNA encoding GFP-2XFYVE
 
Hrs
 
, a GFP fu-
sion protein known to specifically bind PtdIns-3-P (Gillooly
et al., 2000; Maffucci et al., 2003). Confocal microscopy anal-
ysis revealed that in COS7 (Fig. S1 D), HeLa (Fig. 2 A), and
SKOV-3 (Fig. 2 B), LPA stimulation induced a rapid transloca-
tion of GFP-2XFYVE
 
Hrs
 
 to the plasma membrane that paralleled
the time course of PtdIns-3-P formation observed by HPLC
analysis (for COS7 compare Fig. S1 B and histogram in Fig. S1
D; for SKOV-3 compare Fig. 1 B and Fig. S2 B). As shown in
Fig. 2 C, plasma membrane translocation in SKOV-3 was con-
firmed by colocalization of YFP-2XFYVE
 
Hrs
 
 and the plasma
membrane marker CFP-PH PLC
 
 
 
1 (Maffucci et al., 2003).
To investigate the involvement of PI3K in generation of
the LPA-dependent pool of PtdIns-3-P, we performed HPLC
analysis in 
 
3
 
H-labeled SKOV-3 pretreated with different con-
centrations of the reversible PI3K inhibitor LY294002 before
stimulation with LPA. Pretreatment with LY294002 up to 10
 
 
 
M did not inhibit the LPA-mediated formation of PtdIns-3-P
(Fig. 3 A), although it efficiently reduced the basal levels of
PtdIns-3,4,5-P
 
3
 
 (unpublished data) and inhibited the basal
phosphorylation of Akt (Fig. 3 B). Furthermore, TLC analysis
revealed that 10 
 
 
 
M LY294002 completely blocked the EGF-
induced generation of PtdIns-3,4,5-P
 
3
 
 in SKOV-3 and HeLa
(Fig. 3 C). Similarly, pretreatment with 100 nM of the irrevers-
ible PI3K inhibitor wortmannin inhibited the LPA-induced
translocation of the PtdIns-3-P fluorescent probe GFP-
2XFYVE
 
Hrs
 
 to the plasma membrane, whereas 10 
 
 
 
M
LY294002 had almost no effect (Fig. 3, D and E). These data
indicate that LPA generates PtdIns-3-P at the plasma mem-
brane of COS7, HeLa, and SKOV-3 in a mechanism sensitive
to wortmannin but, unlike agonist-induced PtdIns-3,4,5-P
 
3
 
 pro-
duction, more resistant to LY294002.
 
The LPA-dependent pool of PtdIns-3-P is 
involved in cell migration
 
To gain further insight into the LPA signaling in HeLa and
SKOV-3 and precisely assess the role of the LPA-stimulated
pool of PtdIns-3-P, we tested the effects of LPA on cell prolif-
eration and migration in both cell lines. LPA had only a small
effect on cell proliferation in HeLa, whereas it clearly in-
creased cell growth in SKOV-3 (Fig. S3 A, available at http://
www.jcb.org/cgi/content/full/jcb.200408005/DC1). In contrast,
LPA induced migration in both cell lines as assessed by wound
healing (Fig. 4 A; Fig. 5 A; and Fig. S3, B and C) and Trans-
well (Fig. 4 C, Fig. 5 C, and Fig. S3 D) assays. Therefore, we
hypothesized that PtdIns-3-P might be involved in the LPA-
mediated cell motility.
 
Effect of PI3K inhibitors. 
 
To check this hy-
pothesis, we first tested the effect of different concentrations
of PI3K inhibitors on cell migration. Wound healing assay
Figure 2. The LPA-dependent pool of PtdIns-3-P is generated at the
plasma membrane of HeLa and SKOV-3. HeLa (A) and SKOV-3 (B) were
transfected with a cDNA encoding GFP-2XFYVE
Hrs. After 24 h, cells were
serum deprived and stimulated with 25  M LPA for the indicated times be-
fore fixing for confocal microscopy analysis. (C) Confocal microscopy
analysis of SKOV-3 transfected with cDNAs encoding YFP-2XFYVE
Hrs and
CFP-PH PLC 1 and stimulated with 25  M LPA for 10 min. Bars, 10  m. 
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monitored by time-lapse microscopy (Fig. 4, A and B) and
Transwell assay (Fig. 4 C) indicated that a pretreatment with
wortmannin inhibited the LPA-dependent migration. In con-
trast, a concentration of 1 
 
 
 
M LY294002 did not affect the
LPA-dependent migration (Fig. 5, A and B) and 10 
 
 
 
M
LY294002 had only a partial inhibitory effect (Fig. 5, A and
B, wound healing assay monitored by time-lapse micros-
copy; Fig. 5 C, Transwell assay). Together, these data indi-
cate that generation of the LPA-dependent pool of PtdIns-3-P
and the LPA-induced migration show a similar sensitivity to
PI3K inhibitors.
 
Effect of PtdIns-3-P–specific phosphatase.
 
These observations further prompted us to specifically check a
potential role for PtdIns-3-P in LPA-dependent migration.
Therefore, we analyzed migration of SKOV-3 transfected with
a cDNA encoding a Flag-tagged PtdIns-3-P–specific phospha-
Figure 3. Effect of PI3K inhibitors on the LPA-
mediated PtdIns-3-P formation. (A) SKOV-3 were
labeled with [
3H]-myo-inositol for 24 h and left
untreated or pretreated with the indicated concen-
trations of LY294002 before stimulation with 25  M
LPA for 10 min. Phospholipids were then ex-
tracted, deacylated, and analyzed by HPLC.
Levels of PtdIns-3-P are shown as a percentage of
basal levels. (B) Western blotting analysis of lysates
from serum-starved SKOV-3 treated with 100 nM
wortmannin or 10  M LY294002 for 30 min.
Phosphorylation of Akt on residue Ser473 was
assessed by using a specific antibody. Filter was
stripped and reprobed with an anti-Akt antibody.
(C) SKOV-3 (top) and HeLa (bottom) were labeled
with [
32P]phosphoric acid for 3 h and left untreated
or pretreated with 10  M LY294002 before
stimulation with 20 ng/ml EGF for 5 (SKOV-3)
or 1 min (HeLa). Phospholipids were extracted
and analyzed by TLC. (D) GFP-2XFYVE
Hrs-expressing
SKOV-3 cells were pretreated with 100 nM
wortmannin or 10  M LY294002. After 30 min,
cells were stimulated with 25  M LPA for 10 min
before fixing for confocal microscopy analysis.
Bar, 10  m. (E) Quantitative analysis of experi-
ments as in D. Data are mean   SEM of five inde-
pendent experiments.
Figure 4. Effect of wortmannin on the LPA-medi-
ated migration. (A and B) Time-lapse microscopy
of wound healing assay in SKOV-3 pretreated
with the indicated concentrations of wortmannin
for 30 min. Images in A show the wounded cell
monolayers at time 0 and after the indicated hours
in the absence (control) or presence of 25  M LPA
with or without the inhibitor. (B) Quantitative
analysis was performed as described in Materials
and methods. Data are mean   SEM of three to
four independent experiments. (C) Serum-starved
SKOV-3 were pretreated with the indicated con-
centrations of wortmannin for 30 min. Migration
was assessed by Transwell assay in the presence
of 25  M LPA and the indicated concentrations
of the inhibitor. Data are mean   SEM of five
independent experiments and are expressed as a
percentage of LPA-stimulated cells. In these experi-
ments, LPA induced a three- to fourfold increase
in cell migration. 
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tase, myotubularin MTM1 (Laporte et al., 2002), that has been
recently successfully used to inhibit the insulin-dependent pool
of PtdIns-3-P (Chaussade et al., 2003). In these experiments,
migration was assessed in Transwell assays by counting the to-
tal number of migrated cells as described in Materials and meth-
ods. Although the transfection efficiency in SKOV-3 was only
 
 
 
50%, overexpression of MTM1 was able to reduce the LPA-
induced migration whereas overexpression of the point mutant
MTM1 C375S, which has no phosphatase activity toward Ptd-
Ins-3-P, had no effect (Fig. 6 A, top). Expression of both pro-
teins was assessed in Western blotting analysis (Fig. 6 A, bot-
tom). Although expression of MTM1 was able to induce a
partial inhibition of migration, it did not seem to affect the lev-
els of PtdIns-3,4,5-P
 
3
 
 as basal Akt phosphorylation was not
even partially reduced (Fig. 6 B). Importantly, the lack of effect
on Akt phosphorylation was not due to the transfection effi-
ciency because overexpression of the PtdIns-3,4,5-P
 
3
 
–specific
phosphatase PTEN at similar transfection efficiency was in-
deed able to reduce Akt phosphorylation (Fig. 6 C).
 
Effect of PtdIns-3-P–specific binding do-
mains. 
 
We analyzed the LPA-dependent migration in cells
overexpressing the GFP-2XFYVE
 
Hrs
 
 fusion protein that we hy-
pothesized might act as a PtdIns-3-P–sequestering domain and
therefore interfere with the LPA-dependent pool of PtdIns-3-P.
Wound healing assays monitored by confocal microscopy re-
vealed that overexpression of GFP-2XFYVE
 
Hrs
 
 inhibited the
LPA-dependent migration in SKOV-3, whereas overexpression
of GFP alone had no effect (Fig. 6 D). Because none of the GFP-
2XFYVE
 
Hrs
 
-transfected cells were able to migrate into the
wounded area, we could not perform a quantitative analysis of
this assay (Fig. 6 D). Therefore, to quantify the effect of overex-
pression of the PtdIns-3-P–binding domain, we transfected cells
with cDNAs encoding GFP alone or GFP-2XFYVE
 
Hrs
 
 and ana-
lyzed migration by using Transwell assays. In a first set of exper-
iments, we counted the total number of cells migrated after stain-
ing the membranes of the Transwell chambers with crystal violet
and we observed that LPA clearly stimulated migration in GFP-
transfected cells, whereas overexpression of GFP-2XFYVE
 
Hrs
 
partially reduced the LPA-dependent migration (Fig. 6 E). The
observed partial effect was consistent with a transfection effi-
ciency of 
 
 
 
50%, as discussed in the previous paragraph.
To clearly assess the effect of the PtdIns-3-P–sequestering
domain, we performed a very accurate second set of experi-
ments and counted only the transfected (green) cells that had
migrated. Indeed, in this more precise assay we observed that
migration was completely inhibited in cells expressing GFP-
2XFYVE
 
Hrs
 
, whereas cells expressing GFP alone migrated upon
LPA stimulation (Fig. 6 F). As discussed in the previous section,
although a 50% transfection efficiency of GFP-PTEN was
enough to reduce Akt phosphorylation, basal levels of Akt phos-
phorylation were not even partially reduced in cells transfected
with GFP-2XFYVE
 
Hrs
 
 with the same efficiency (Fig. 6 G).
When we performed similar experiments in HeLa we ob-
served a total inhibition of the LPA-mediated migration in cells
expressing GFP-2XFYVE
 
Hrs
 
, a finding consistent with the high
transfection efficiency of these cells (
 
 
 
80%; Fig. 6, H and I;
and Fig. S3 E). To further confirm that inhibition of migration
was due to a specific sequestering of PtdIns-3-P, we transfected
Figure 5. Effect of LY294002 on the LPA-mediated
migration. (A and B) Time-lapse microscopy of
wound healing assay in SKOV-3 pretreated with
the indicated concentrations of LY294002 for 30
min. Images in A show the wounded cell monolay-
ers at time 0 and after the indicated hours in the
absence (control) or presence of 25  M LPA with
or without the inhibitor. (B) Quantitative analysis
was performed as described in Materials and
methods. Data are mean   SEM of three to five
independent experiments. (C) Serum-starved
SKOV-3 were pretreated with the indicated con-
centrations of LY294002 for 30 min. Migration
was assessed by Transwell assay in the presence
of 25  M LPA and the indicated concentrations of
the inhibitor. Data are mean   SEM of five inde-
pendent experiments and are expressed as a
percentage of LPA-stimulated cells. In these experi-
ments, LPA induced a three- to fourfold increase in
cell migration.JCB • VOLUME 169 • NUMBER 5 • 2005 794
HeLa with a cDNA encoding another fusion protein also
known to bind PtdIns-3-P (GFP-PX p40
phox) that we have al-
ready used to monitor the intracellular PtdIns-3-P (Maffucci et
al., 2003). As a control we used a mutant of this domain with a
reduced ability to bind PtdIns-3-P (GFP-PX p40
phox Y59A/
L65Q). GFP-PX p40
phox inhibited the LPA-mediated migration,
whereas less effect was observed in cells transfected with the
mutated version of the protein (Fig. 6, H and I). Similar results
were obtained in Transwell assay (Fig. S3 E). Overexpression
of these domains did not affect cell growth (Fig. S3 F).
Together these data indicate that the lipid second messen-
ger PtdIns-3-P is a new effector in LPA cascade and plays a
role in the LPA-mediated cell migration.
The LPA-dependent pool of PtdIns-3-P is 
generated through PI3K-C2  activation
The observation that in HeLa and SKOV-3 LPA did not affect
the levels of PtdIns-3,4,5-P3, the major in vivo product of class
I PI3Ks, together with the observed resistance to the inhibitor
LY294002 ruled out the possibility that PtdIns-3-P derives
from activation of the class I PI3Ks. This finding is in agree-
ment with recent data indicating that the LPA-dependent mi-
gration of SKOV-3 requires activation of a Ras–MEK kinase 1
pathway but not class I PI3K (Bian et al., 2004). Several lines
of evidence suggest that, at least in insulin signaling, the stimu-
lated pool of PtdIns-3-P is the product of a class II PI3K (Maf-
fucci et al., 2003). Moreover, the high sensitivity to wortmannin
and reduced sensitivity to LY294002 observed in this study
was in agreement with observed in vitro sensitivities of the
class II enzyme PI3K-C2  to these inhibitors and is distinct
from that observed for class I enzymes (Arcaro et al., 1998;
Fig. S4, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200408005/DC1). On the basis of these observations,
we hypothesized that the LPA-dependent pool of PtdIns-3-P
might be generated through activation of a class II PI3K.
To investigate this hypothesis, we examined the effect of
specific inhibition of these isoforms on the LPA-dependent
generation of PtdIns-3-P at the plasma membrane. As there are
no class II PI3K-specific chemical inhibitors available, we used
RNA interference to specifically knockdown the class II iso-
forms PI3K-C2  and PI3K-C2 . Then, we analyzed the intra-
cellular localization of GFP-2XFYVE
Hrs in LPA-stimulated
SKOV-3 transfected with the corresponding siRNAs. A com-
plete inhibition of LPA-dependent GFP-2XFYVE
Hrs plasma
Figure 6. PtdIns-3-P is involved in the LPA-
mediated migration of SKOV-3. (A-G) SKOV-3
were transiently transfected with the indicated
cDNAs. Transfection efficiency in these cells
was  50%. (A, top) SKOV-3 were transfected
with cDNAs encoding Flag-MTM1 and Flag-
MTM1 C375S. After 24 h, cells were serum
deprived overnight and migration was assessed
by Transwell assay in the presence of 25  M
LPA. The total number of migrated cells was
counted after staining the membranes of the
Transwell chambers with crystal violet. Data
are mean   SEM of three independent experi-
ments. *, P   0.05. (bottom) Representative
blot monitoring the levels of expression of
Flag-MTM1 and Flag-MTM1 C375S by using
an anti-Flag antibody. (B) Phosphorylation of
Akt on residue Ser473 assessed in lysates
from SKOV-3 transfected with an empty vector
or cDNAs encoding Flag-MTM1 and Flag-
MTM1 C375S. Filters were stripped and rep-
robed with an anti-Akt antibody. (C) Phosphor-
ylation of Akt on residue Ser473 assessed in
lysates from SKOV-3 transfected with cDNAs
encoding GFP or GFP-PTEN. Filters were
stripped and reprobed with an anti-Akt anti-
body. Expression of the exogenous proteins
was assessed by using an anti-GFP antibody.
Images are from different lanes in the same
blot. (D) SKOV-3 grown on glass coverslips
were transfected with cDNAs encoding GFP
or GFP-2XFYVE
Hrs. After 24 h, cells were se-
rum deprived overnight and migration was as-
sessed by wound healing assay. After wounding and further 24 h in the presence of 25  M LPA, cells were fixed and analyzed by confocal microscopy.
Actin was stained by using Alexa 594 phalloidin and the merged images are shown. Diagonal lines specify the position of the original wound. (E and F)
SKOV-3 were transfected as in D. Migration was then assessed by Transwell assay in the presence of 25  M LPA. For data shown in E, the total number
of cells that had migrated was counted after staining the membranes of the Transwell chambers with crystal violet. Data are mean   SEM from three
independent experiments performed in duplicate. *, P   0.05. For data shown in F, the membranes of the Transwell chambers were fixed and analyzed
by fluorescent microscopy to visualize and count only transfected (green) cells that had migrated. Data are mean   SEM from four independent experiments.
(G) Phosphorylation of Akt on residue Ser473 assessed in lysates from SKOV-3 transfected with cDNAs encoding GFP or GFP-2XFYVE
Hrs. Filters were
stripped and reprobed with an anti-Akt antibody. (H–I) HeLa were transfected with cDNAs encoding the indicated fusion proteins (transfection efficiency
was  80%). After 24 h, cells were serum deprived overnight and wound healing was performed in the presence of 25  M LPA. (H) Representative phase-
contrast images of the wounded cell monolayers at time 0 and after 24 h of migration. (I) Quantitative analysis of wound healing as in H. Data are mean  
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membrane translocation was observed in SKOV-3 transfected
with the PI3K-C2  siRNA. No inhibition was observed in cells
transfected with the PI3K-C2  siRNA (Fig. 7, A and B). The
observed complete inhibition was consistent with a high uptake
of siRNAs in SKOV-3 that was confirmed by Western blotting
analysis showing that a  90% knockdown of protein expres-
sion was achieved (Fig. 7 C). The higher transfection effi-
ciency compared with plasmid DNAs is in agreement with re-
ported high uptake of siRNAs in cells (Holen et al., 2002;
Splinter et al., 2003). The LPA-dependent activation of PI3K-
C2  was confirmed by in vitro lipid kinase assay (Fig. 8 A). In
the same experiments, no activation of PI3K-C2  was ob-
served (unpublished data). In addition, we observed that LPA
induced the translocation of a myc-tagged version of PI3K-
C2  to the plasma membrane in both HeLa (Fig. 8 B) and
SKOV-3 (Fig. 8 C), suggesting that formation of PtdIns-3-P
might occur through an LPA-dependent targeting and subse-
quent activation of the enzyme at the plasma membrane.
PI3K-C2  is necessary for LPA-dependent 
migration
We investigated the potential role of class II PI3Ks in the LPA-
mediated cell migration by performing migration assays on
cells transfected with the isoform-specific siRNAs. Wound
healing assay monitored by time-lapse microscopy revealed that
knockdown of PI3K-C2  expression inhibited cell migration in
SKOV-3 (Fig. 9 A). Similar results were obtained in wound
healing assay performed in HeLa (Fig. S4 C). In both cases no
effect was observed in cells transfected with the PI3K-C2 
siRNA. Similarly, knockdown of PI3K-C2  expression com-
pletely inhibited cell migration assessed by Transwell assay
both in SKOV-3 (Fig. 9 B) and HeLa (Fig. 9 C). Representative
fields of migrated HeLa in Transwell assay are shown in Fig. 9
D. The complete inhibition of migration was consistent with the
high uptake of siRNAs in these cells (Western blotting analysis
for HeLa is shown in Fig. S4 D). These data indicate that PI3K-
C2  plays an important role in the LPA-dependent migration.
Discussion
LPA activates the class II enzyme PI3K-
C2  and generates the lipid second 
messenger PtdIns-3-P
A role for PtdIns-3-P as an intracellular second messenger has
been suggested by the recent demonstration that this phospho-
inositide plays an important role in insulin signaling (Chaus-
Figure 7. Knockdown of PI3K-C2  completely inhibits the LPA-mediated
PtdIns-3-P formation. (A) SKOV-3 were transfected with oligofectAMINE
alone or with siRNAs corresponding to PI3K-C2  and PI3K-C2  and
further transfected with a cDNA encoding GFP-2XFYVE
Hrs. After 24 h, cells
were serum deprived overnight and stimulated with 25  M LPA for 10 min
before fixing for confocal microscopy analysis. Bar, 10  m. (B) Quantitative
analysis of GFP-2XFYVE
Hrs translocation to the plasma membrane in
SKOV-3 as in A. Data are mean   SEM from three independent experi-
ments. (C) Representative blots of lysates from SKOV-3 transfected with
oligofectAMINE or the indicated siRNAs. Levels of PI3K-C2  and PI3K-
C2  were assessed by using specific antibodies.
Figure 8. PI3K-C2  is a downstream effector of LPA. (A) PI3K-C2  activity
was assessed in LPA-stimulated HeLa by in vitro kinase assay as described
in Materials and methods. Data are mean   SEM of three independent
experiments. (B and C) HeLa (B) and SKOV-3 (C) were transfected with a
cDNA encoding a myc-tagged PI3K-C2 . After 24 h, cells were serum
deprived overnight and stimulated with 25  M LPA for the indicated times
before fixing for confocal microscopy analysis. Bar, 10  m.JCB • VOLUME 169 • NUMBER 5 • 2005 796
sade et al., 2003; Maffucci et al., 2003). Here, we demonstrate
that LPA can generate PtdIns-3-P at the plasma membrane of
COS7, HeLa, and the ovarian cancer cell line SKOV-3, which
indicates that pools of PtdIns-3-P can be generated by different
stimuli and therefore PtdIns-3-P might play a more general role
in signal transduction. The LPA-mediated generation of Ptd-
Ins-3-P seems to be very specific, at least in HeLa and SKOV-3,
because in our experimental conditions we did not detect any
formation of PtdIns-3,4,5-P3 either by HPLC or TLC analysis.
These data indicate that, at least in these cells, formation of Ptd-
Ins-3-P does not involve activation of p110  or p110 , the
members of class I PI3K most frequently associated with LPA
signaling (Yart et al., 2002). Furthermore, generation of this
LPA-dependent pool of PtdIns-3-P is sensitive to treatment
with 100 nM of the PI3K inhibitor wortmannin but is more re-
sistant to treatment with concentrations of LY294002 up to 10
 M, known to completely block class I PI3K. Such sensitivity
to the PI3K inhibitors is consistent with observed in vitro sensi-
tivities of the class II enzyme PI3K-C2  (Arcaro et al., 1998;
Fig. S4, A and B). This observation together with our evidence
suggesting that the insulin-dependent pool of PtdIns-3-P is
generated through a class II PI3K-mediated mechanism led us
to hypothesize that the LPA-dependent pool of PtdIns-3-P
might be the product of a class II PI3K.
There is currently a growing interest in class II PI3Ks be-
cause several lines of evidence suggest that different agonists
can activate these enzymes; however, their precise intracellu-
lar role and their lipid products in vivo still remain to be estab-
lished (Foster et al., 2003). Here, we show that LPA activates
PI3K-C2  and that knockdown of this enzyme specifically in-
hibits formation of PtdIns-3-P at the plasma membrane upon
LPA stimulation. This is the first paper showing that PI3K-
C2  is activated and PtdIns-3-P is generated upon LPA stimu-
lation, and therefore, this work identifies a novel PI3K-C2 –
PtdIns-3-P pathway in LPA signaling. Furthermore, this study
is the first clear indication that PtdIns-3-P might be the in vivo
product of PI3K-C2 .
The PI3K-C2 –PtdIns-3-P pathway is 
involved in the LPA-dependent cell 
migration
The observation that the sensitivity to PI3K inhibitors of LPA-
dependent migration is very similar to the effect observed on
PtdIns-3-P formation led us to hypothesize that this pathway
might be involved in the LPA-dependent cell migration. As for
PtdIns-3-P formation, treatment with 100 nM wortmannin
blocked migration whereas 1  M LY294002 had no effect and
10  M LY294002 had a partial effect on the LPA-mediated
Figure 9. PI3K-C2  is involved in LPA-mediated cell migration. (A) Time-lapse microscopy of wound healing assay in serum-deprived SKOV-3 transfected
with oligofectAMINE or the indicated siRNAs. Images show two opposite sides of the same representative fields of the recorded wounded area at time 0
and at the indicated hours in the presence of 25  M LPA. (B) Transwell assay of serum-deprived SKOV-3 transfected with oligofectAMINE or with the indicated
siRNAs. Data are mean   SEM of four independent experiments performed in duplicate. (C) Transwell assay of serum-deprived HeLa transfected with
oligofectAMINE or with the indicated siRNAs. Data are mean   SEM of three independent experiments. (D) Representative phase-contrast images of
migrated HeLa in Transwell assay as in C obtained by staining the membranes of the Transwell chambers with crystal violet.ROLE OF CLASS II PI3K IN CELL MIGRATION • MAFFUCCI ET AL. 797
migration. Sensitivity to LY294002 is a key feature of PI3K-
C2  that shows a different sensitivity to this inhibitor com-
pared with class I PI3K (Fig. S4 B). In particular, 1  M
LY294002, although able to significantly inhibit class I PI3K,
has no effect on the activity of PI3K-C2 . More crucially, a
concentration of 10  M LY294002 completely blocks class I
PI3K, whereas it has only a partial inhibitory effect on PI3K-
C2 . It is important to underline that 10  M LY294002 repre-
sents a crucial point in the curve of sensitivity of PI3K-C2 
that is where the activity of the enzyme significantly drops
(Fig. S4 B). The observation that 10  M LY294002 corre-
sponds to the slope in the curve of sensitivity of PI3K-C2 
might explain the variability in the results that in some experi-
ments was associated with the use of such concentration of the
inhibitor (e.g., see the high SEM associated with the PtdIns-3-P
formation in Fig. 3 A). However, even taking into account such
variability, it is clear that both the LPA-dependent generation
of PtdIns-3-P and migration are quite resistant to treatment
with LY294002, and this finding is consistent with the ob-
served sensitivity of PI3K-C2 .
Specific blockade of PtdIns-3-P (by overexpression of ei-
ther a PtdIns-3-P–specific phosphatase or PtdIns-3-P–binding
domains) blocks the LPA-dependent migration. In SKOV-3,
the observed effects were partial when we counted the total
number of migrated cells, and this result is consistent with a
partial transfection efficiency of plasmid DNAs in SKOV-3
( 50%). However, when we monitored migration only in
transfected (green) SKOV-3, we observed a complete inhibi-
tion of migration. Similarly, inhibition of migration was com-
plete in HeLa whose transfection efficiency was  80%. Addi-
tionally, knockdown of PI3K-C2  in both cell lines inhibits the
LPA-mediated migration. Together, these data indicate that
this newly identified PI3K-C2 –PtdIns-3-P signaling pathway
is necessary for the LPA-dependent cell migration. These data
represent the first clear identification of an intracellular role for
a member of class II PI3K and they may shed new light on
PI3K-mediated intracellular events.
Over the last decade wide interest has been focused on
understanding the mechanisms underlying the major steps of
cell migration and the signaling pathways regulating them. On
the one hand, cell migration plays a crucial role in a variety of
biological processes such as morphogenesis, inflammation, and
wound healing. On the other hand, migration is involved in
several diseases, including cancer metastasis, atherosclerosis,
and arthritis. Therefore, the identification of both PI3K-C2 
and PtdIns-3-P as important players in cell migration may help
clarify both physiological and pathological mechanisms of cell
migration and represent a novel target for therapeutic interven-
tion. Several lines of evidence are now revealing the crucial
role for LPA as a motility factor. It has been shown that in hu-
man pancreatic carcinoma cell lines LPA stimulates cell migra-
tion but not proliferation (Stahle et al., 2003). More interest-
ingly, LPA has been identified as a critical component of
ascites for the motility of pancreatic cancer cells (Yamada et
al., 2004). In addition, it has been reported that the ectoenzyme
autotaxin, a cell motility-stimulating ectophosphodiesterase,
can generate LPA in the extracellular environment (Umezu-
Goto et al., 2002), and both LPA and autotaxin are involved in
motility of neoplastic and nonneoplastic cells (Hama et al.,
2004). These data, together with the observation that elevated
plasma LPA concentrations have been found in patients with
ovarian cancer compared with healthy control group (Xu et al.,
1995; Westermann et al., 1998) and that prostate cancer cells
produce high levels of LPA (Xie et al., 2002), definitively sup-
port a role for LPA in the initiation or progression of malignant
disease (Mills and Moolenaar, 2003).
The discovery of this novel PI3K-C2 –PtdIns-3-P path-
way in LPA-dependent migration of different cell lines, includ-
ing an ovarian cancer cell line, may therefore result useful in
elucidating the role of LPA in this disease. Furthermore, because
a wide range of mammalian cell types are LPA-responsive, it is
tempting to speculate that the PI3K-C2 –PtdIns-3-P pathway
might have a more general role in different biological contexts.
Materials and methods
Materials and plasmids
L- -LPA, oleoyl (C18:1,[cis]-9), anti-myc, anti– -actin, and anti-Flag were
purchased from Sigma-Aldrich; anti-Akt, anti-pSer473Akt, and anti-
pThr308 from Santa Cruz Biotechnology, Inc.; anti-HA from Boehringer;
anti-p85 from Upstate Biotechnology; anti-PI3K-C2  and anti-GFP from BD
Biosciences; and Alexa 594 phalloidin from Molecular Probes. Anti-PI3K-
C2  was a gift of P.R. Shepherd (University of Auckland, Auckland, New
Zealand). Flag-MTM1 and Flag-MTM1 C375S were a gift of J. Laporte (In-
stitut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch,
France). myc-PI3K-C2  was provided by M.D. Waterfield (The Ludwig In-
stitute for Cancer Research, London, UK). Chemically synthesized double-
stranded siRNAs with 19-nucleotide duplex RNA and 2-nucleotide 3  dTdT
overhangs were purchased from Dharmacon or Eurogentec. To design
class II PI3K-specific siRNAs, the human PI3K-C2  (GenBank/EMBL/DDBJ
accession no. NM 002645) and PI3K-C2  (GenBank/EMBL/DDBJ acces-
sion no. NM 002646) mRNA sequences were searched for 21-nucleotide
unique sequences using the National Center for Biotechnology Information
database and the BLAST search algorithm. The cDNA sequences against
which siRNAs were prepared are 5 -AAGTCCAGTCACAGCGCAAAG-3 
(nucleotides 1224–1244) for PI3K-C2  and 5 -AAGAATGCGACGCCTG-
GCAAG-3  (nucleotides 1368–1388) for PI3K-C2 .
Cell cultures and transfection
Cells were maintained in DME supplemented with 10% FBS and trans-
fected with LipofectAMINE PLUS (Invitrogen) according to the manufac-
turer. Transfection with siRNAs was performed as described previously (El-
bashir et al., 2002) and cells were used after 48–72 h.
HPLC analysis
COS7, HeLa, and SKOV-3 were incubated with 10  Ci/well  myo-
[
3H]inositol (PerkinElmer) in inositol-free medium M199 for 24 h, and then
left untreated or stimulated with LPA for different times. HPLC analysis was
performed as described previously (Maffucci et al., 2003).
TLC analysis
Serum-starved cells were incubated with 0.8 mCi/well [
32P]phosphoric
acid (PerkinElmer) in phosphate-free medium, M3786, for 3 h before stim-
ulation as indicated. Phospholipids were extracted, dried under nitrogen,
resuspended in 100  l chloroform/methanol (3:2), and spotted onto silica
plates presoaked in water/methanol (3:2) and 1.2% (wt/vol) oxalic acid,
and oven baked for 15 min at 110 C. TLC plates were developed in chlo-
roform/acetone/methanol/acetic acid/water (90:36:30:27:18).
Confocal microscopy and quantitative analysis
Cells grown on glass coverslips were fixed with PBS containing 4% PFA for
10 min at RT. Where necessary, cells were permeabilized with 0.25% Tri-
ton X-100 and incubated with an anti-myc antibody followed by an FITC
secondary antibody. Microscopy was performed by using a laser confocal
microscope system (TCS NT; Leica) connected to a microscope (model
DMXRE; Leica) equipped with a 63  water immersion objective. Images
were acquired and loaded by using a TCS NT program (version 1.6.587).JCB • VOLUME 169 • NUMBER 5 • 2005 798
No further processing of the images was done except for changes in bright-
ness/contrast to better visualize the data. For quantitative analyses of GFP-
2XFYVE
Hrs translocation, GFP-2XFYVE
Hrs-transfected cells were serum starved
for 24 h and stimulated with LPA for the indicated times before fixing for
confocal microscopy. At least 100 cells/coverslip were analyzed by blind
scoring (no score: cells with 0–25% membrane localization; score 1: cells
with  25% membrane localization). The number of cells showing a plasma
membrane localization of the GFP-2XFYVE
Hrs was expressed as a percent-
age of control. Statistical analyses were performed by paired t test.
PI3K assay
PI3K activity assay was performed as described previously (Kamalati et
al., 2000).
Migration assays
Wound healing assay. Confluent cells were serum deprived overnight, left
untreated or treated as indicated, and then wounded with a linear scratch
by a sterile pipette tip. After washing, cells were incubated in the presence
or absence of LPA and 0.5  g/ml mitomycin-C. Time-lapse microscopy
was performed by using a microscope (model Eclipse TE2000-U; Nikon)
equipped with a temperature controller (Solvent Scientific; 37 C). No fur-
ther processing of the images was done except for changes in brightness/
contrast to better visualize the data. Cell movement was recorded with a
charge-coupled device camera (OrcaER; Hamamatsu Photonics) by using
PCI Software (Digitalpixel). To obtain the quantitative analyses of Fig. 4 B
and Fig. 5 B, panels as those shown in Fig. 4 A and Fig. 5 A were pre-
pared for each experiment. Each panel was made up of images of cells
collected at time 0 and every hour (1–17 h) for each condition (control,
LPA, and different concentrations of PI3K inhibitors LPA). The wounded
area was defined in each image by positioning red lines in correspon-
dence of the original scratch. The number of cells migrated into the
wounded area at different hours was visually counted. Alternatively, the
wounded cell monolayers were photographed using a microscope (Ni-
kon). For quantitative analysis shown in Fig. 6 I, experiments were per-
formed in cell culture dishes with a 2-mm grid (Nunc) and migration was
quantified by counting the number of cells per grid square (4 mm
2) by us-
ing a microscope (Nikon).
Transwell assay. Alternatively, cell migration was performed in Tran-
swell chambers (tissue culture treated, 10-mm-diam, 8  m pores; Nunc)
coated with 100  g/ml of type I collagen. Cells were resuspended in DME
containing 1% BSA, added (30,000 cells/150  l) to the top of each migra-
tion chamber, and allowed to migrate in the presence of LPA in the lower
chamber. After 4 h, cells that had not migrated were removed using a cot-
ton swab, whereas migrated cells were fixed with 4% PFA. To count the to-
tal number of migrated cells, the membranes of the Transwell chambers
were stained with 1% crystal violet and analyzed by phase-contrast micros-
copy using a microscope (Nikon; examples are shown for HeLa in Fig. 9 D).
To count only the transfected cells, we took advantage of the observation
that they expressed GFP-tagged proteins. Therefore, the Transwell chambers
were analyzed by fluorescent microscopy using a microscope (model DM-
RXE; Leica) equipped with a 10  objective. In this way, only fluorescent
(green) cells that had migrated were visualized and counted.
Cell growth
10
4 cells/well in a 48-well plate were serum deprived overnight before
adding LPA for a further 48 h. [
3H]thymidine (0.5  Ci/well) was added
for the last 18 h. After washing with ice-cold PBS, wells were incubated
with 5% TCA at  4 C for 20 min, washed with PBS and methanol, and
air dried. After 30 min in 0.2 M NaOH, samples were collected and ra-
dioactivity was assessed by scintillation counting. Alternatively, MTT assay
was performed as described previously (Piccolo et al., 2004).
Phospholipase C activation
Cells were incubated with 2  Ci/well myo-[
3H]inositol (PerkinElmer) in
M199. After 24 h, cells were incubated in M199 plus 10 mM Hepes and
20 mM LiCl for 15 min before stimulation, scraped in 0.1 M HCOOH,
and the total amount of inositol phosphates was assessed using AG 1-X8
resin (formate form, 200–400 mesh; Bio-Rad Laboratories) and liquid ra-
dioactivity counting.
Online supplemental material
Fig. S1, Fig. S2, Fig. S3, Fig. S4 and the corresponding legends are avail-
able in the online supplemental material. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200408005/DC1.
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